Day: April 10, 2026

Pharmacovigilance Mandates and Regulations in India Key Insights about the CDSCO Framework
By Vigilare Biopharma April 10, 2026Pharmacovigilance

Pharmacovigilance Mandates and Regulations in India Key Insights about the CDSCO Framework

India’s pharmaceutical market continues to expand, and with the growth comes greater responsibility for drug safety oversight. The Central Drugs Standard Control Organization (CDSCO) plays a central role in shaping the country’s pharmacovigilance framework. Key

Read More
The Rising Bar of the Indian Pharma Sector
By Vigilare Biopharma April 10, 2026Pharmacovigilance

The Rising Bar of the Indian Pharma Sector Regulatory Readiness for Foreign Manufacturers

India’s pharmaceutical sector is evolving from high-volume output to strategic global importance. The domestic market, currently USD 50–60 billion, is projected to reach USD 130 billion by 2030. With FY2026 growth forecasts of 7%–11%, India

Read More